Summarized by Masters of Longevity from Fight Aging!.
Therapies targeting the biology of aging — a persuasive policy and investment argument for their potential to become a major economic productivity lever.
Key Takeaways
- Developing therapies that repair root causes of aging could substantially reduce midlife and later health decline, increasing workforce participation and productivity.
- Rapid, system-level longevity treatments could create non-linear changes in lifespan that challenge existing economic, healthcare, and pension planning models.
- Framing and funding aging-targeting research as an economic priority would accelerate investment in translational work, clinical trials, and public-private partnerships.
